{"chebi_id":"52172","chebi_name":"nilotinib","chebi_synonyms":["AMN 107","nilotinibum","AMN107","4-methyl-N-[3-(4-methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)phenyl]-3-[(4-pyridin-3-ylpyrimidin-2-yl)amino]benzamide"],"diffprof_id_observed":["MTBLS2406_0001_00000009"],"diffprof_id_var_observed":["MTBLS2406_0001_00000009"],"inchikey":"HHZIURLSWUIHRB-UHFFFAOYSA-N","inn_name":"nilotinibum","iupac_name":"4-methyl-<em>N</em>-[3-(4-methyl-1<em>H</em>-imidazol-1-yl)-5-(trifluoromethyl)phenyl]-3-[(4-pyridin-3-ylpyrimidin-2-yl)amino]benzamide","num_study_observed":1,"reactome_ids":["R-HSA-1433557","R-HSA-162582","R-HSA-1643685","R-HSA-186797","R-HSA-5663202","R-HSA-9006934","R-HSA-9669921","R-HSA-9669926","R-HSA-9669937","R-HSA-9669938","R-HSA-9671555","R-HSA-9674428"],"reactome_names":["Signaling by SCF-KIT","Signal Transduction","Disease","Signaling by PDGF","Diseases of signal transduction by growth factor receptors and second messengers","Signaling by Receptor Tyrosine Kinases","KIT mutants bind TKIs","Nilotinib-resistant KIT mutants","Drug resistance of KIT mutants","Signaling by KIT in disease","Signaling by PDGFR in disease","PDGFR mutants bind TKIs"],"study_id_observed":["MTBLS2406"],"study_id_var_observed":["MTBLS2406"],"synonym_name":"AMN107"}